TRPV4 and proximal spinal muscular atrophy: These data also confirm that CHCHD10 mutations, which are frequent in the Finnish population of non-5q proximal SMA patients, and the previously described TRPV4 and VAPB mutations are not a major feature in the French population [18, 19].